Company profile
Tusk Therapeutics Ltd
Home
As a pioneer in healthcare, we have been committed to improving lives since the company was founded in 1896 in Basel, Switzerland. Today, Roche creates innovative medicines and diagnostic tests that help millions of patients globally.
Corporate ownership
Updated 06 Jun 2026 16:52
Company events
Reference milestones and recent Companies House filing stream events.
Accounts due
Accounts DueNext accounts due date
Confirmation statement due
Confirmation DueNext confirmation statement due date
Accounts filed
AccountsLast accounts made up date
Confirmation statement filed
ConfirmationLast confirmation statement made up date
Confirmation Statement With No Updates
Confirmation-statementCS01 | Transaction MzQzNTk4Njk0MmFkaXF6a2N4
Published 16 Sep 2024 10:15
Accounts With Accounts Type Full
Accounts PDF pendingAA | Transaction MzQzMjE0NzQzMWFkaXF6a2N4 | Paper/PDF filed
Published 20 Aug 2024 08:00
Incorporated
InceptionCompany registered at Companies House
Public funding
Projects
Novel CD38 Targeting Cancer Immunotherapy
1 Jan 2018 to 30 Apr 2020
Tusk Therapeutics is a UK biotechnology company with a focus on harnessing the power of the immune system to fight cancer through the development of novel immune modulating therapeutics. The company has established a diversified pipeline of antibodies against both novel and validated targets that play an important role in the body’s immune response to can...